Meg Alexander

Meg Alexander serves as President & COO at Ovid Therapeutics. Ovid Therapeutics operates in the research sector with approximately 41.0 employees. The company is headquartered in New York, New York. Ovid Therapeutics generates annual revenue of 566000.0.

Industry & Role Insights

• • MessageCEO tracks 2,961 executives in the research sector.
• • 6,952 executive contacts are available in New York.
• • Our database includes 201,468 c suite-level executives.

Mimecast Pardot Microsoft Office 365 Google Cloud Hosting BugHerd WordPress.org Google Tag Manager YouTube reCAPTCHA Google Analytics Mobile Friendly Nginx Render Remote Circle

biotechnology: pharmaceutical preparations health care biotechnology research epilepsy seizure neurological disorders biopharmaceuticals small molecule therapies gaba aminotransferase inhibitor rock2 inhibitor kcc2 activator targeted therapies first-in-class best-in-class clinical development drug pipeline patient advocacy treatment-resistant epilepsy therapeutic area neurodevelopmental conditions neuropsychiatric disorders rare diseases oral medication intravenous administration patient safety clinical trials phase 1 phase 2 pharmacokinetics seizure reduction adaptive trial design neuroscience innovative treatments safety & tolerability patient experience biotechnology collaborative partnerships investor relations scientific strategy research development clinical assets medical breakthroughs treatment options healthcare innovation therapeutic mechanisms neuron excitability cns disorders seizure management healthcare outcomes research partnerships patient communities scientific collaborations drug discovery seizure disorders patient-centric approach innovative medicines neuronal hyperexcitability treatment-resistant seizures cerebral cavernous malformations neurovascular conditions neuro-inflammatory conditions drug development quality of life unmet medical needs kcc2 activators rock2 inhibitors therapeutic pipeline patient insights partnerships collaborations neurotherapeutics pediatric epilepsy adult epilepsy anti-psychotic effects anticonvulsant effects next-generation therapies patient outcomes scientific research community engagement health wellness & fitness hospital & health care

SN

Srikanth Nandiraju Chief Technology Officer at 1Cell.Ai Inc.

SD

Surinnder Dang Chief Business Officer at 1Cell.Ai Inc.

M

Mark Chief Executive Officer at 23Strands

IT

Ilia Tikhomirov Chief Executive Officer at 35Pharma

AD

Alistair Draffan Chief Executive Officer at 360biolabs Pty Ltd

Outreach Guidance — research Sector

Executives like Meg Alexander in the research sector receive targeted outreach from sales teams, recruiters, and investors. To stand out, personalize your message with industry-specific context and a clear, specific value proposition relevant to their role at Ovid Therapeutics.

Meg Alexander's Position in the MessageCEO Database

• •Meg Alexander is 1 of 1 verified executive contact we track at Ovid Therapeutics.
• •2,871 verified executive contacts in research are in the MessageCEO database.
• •6,778 verified executive contacts in New York are in the database.
• •28 verified contacts work at research companies in the 41.0 employee range (same size as Ovid Therapeutics).

Executive contact data compiled from public business filings, LinkedIn public profiles, company press materials, and verified outbound email testing. We do not publish personal addresses or sensitive identifiers. Methodology & sources · Removal requests handled at /remove-info · Updated July 2026.

How do I reach Meg Alexander directly?

Meg Alexander's verified email address is available to MessageCEO Pro subscribers. They currently serve as President & COO at Ovid Therapeutics. Access direct contact info to skip gatekeepers and reach the decision maker.

What company does Meg Alexander work for?

Meg Alexander is President & COO at Ovid Therapeutics, a company in the research sector with 41.0 employees. The company is based in New York, New York.

Can I pitch or sell to Meg Alexander?

As President & COO at Ovid Therapeutics, Meg Alexander is a key decision-maker in the research sector. MessageCEO Pro gives you verified email to reach Meg Alexander directly — ideal for B2B sales, partnerships, and executive recruiting.

What industry is Meg Alexander in?

Meg Alexander works in the research industry as President & COO at Ovid Therapeutics. MessageCEO provides verified contact information for executives across all major industries.

Is Meg Alexander's contact information verified?

Yes. MessageCEO verifies executive contact information through multiple data sources and regular validation checks. Meg Alexander's profile is kept up-to-date with the latest available information.

Last updated: July 26, 2026